Early effects predict trajectories of response to esketamine in treatment-resistant depression.
Estrade I, Petit AC, Sylvestre V, Danon M, Leroy S, Perrain R, Vinckier F, Mekaoui L, Gaillard R, Advenier-Iakovlev E, Mancusi RL, Poupon D, De Maricourt P, Gorwood P.
Estrade I, et al. Among authors: vinckier f.
J Affect Disord. 2023 Dec 1;342:166-176. doi: 10.1016/j.jad.2023.09.030. Epub 2023 Sep 20.
J Affect Disord. 2023.
PMID: 37738705